Experimental work on wet granulation demonstrates the use of dynamic powder characterization to support continuous processing for tablet manufacturing.
*** Live: Thursday, November 5, 2020 at 11am EST | 8am PST | 4pm GMT | 5pm CET***At the center of every clinical trial is a patient awaiting treatment. Learn from the experts on how to design a decentralized clinical trial to improve patient recruitment and retention. ***On demand available after final airing until Nov. 5, 2021***
Wednesday, June 30, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST
Webinar Date/Time: Wed, Mar 26, 2025 1:30 PM EDT
Preventative maintenance of heat transfer fluid systems is important for reducing downtime in pharmaceutical manufacturing.
As regulatory authorities crack down on data integrity violations, bio/pharma companies must ensure adequate data governance programs are in place.
As regulatory authorities crack down on data integrity violations, bio/pharma companies must ensure adequate data governance programs are in place.
As regulatory authorities crack down on data integrity violations, bio/pharma companies must ensure adequate data governance programs are in place.
GMP non-compliance can spill over and impact patient access to life-saving medications.
In Part I of this article series, the authors discussed the regression control chart method for identifying out-of-trend data in pharmaceutical stability studies. In Part II, the by-time-point method and the multivariate control chart method are investigated, and improved approaches are suggested. The method is illustrated using real data sets.
In Part I of this article series, the authors discussed the regression control chart method for identifying out-of-trend data in pharmaceutical stability studies. In Part II, the by-time-point method and the multivariate control chart method are investigated, and improved approaches are suggested. The method is illustrated using real data sets.
Traditional project decision-making is compared with a QbD approach.
Understanding the relative strengths and weaknesses of different endotoxin test methods is crucial to maintaining quality and patient safety.
Model-based formulation and technology selection methodologies facilitate rapid product development.
Innovative approaches to drug screening—such as evaluation to identify the optimal solid state of a molecule and in-vitro characterization to establish the optimal solid state of a molecule and the ideal bioavailability-enhancing technology—can help drug developers meet accelerated development timelines while managing risk.
Investing in a single source enterprise-wide LMS to fuel risk management and mitigation offers multi-dimensional return on investment.
Lyophilisation or freeze-drying is widely used in the pharmaceutical industry for a variety of reasons.
Understanding what affects a measurement and implementing appropriate procedures will aid weighing accuracy.
Challenge trials may increase in coming years as new and improved challenge agents better emulate “natural” disease states.
A new facility type integrates next-generation mobile cleanroom systems.
Alternatives to time-consuming, error-prone operations promise to reduce vaccine manufacturing costs and improve facility flexibility.
This article discusses the potential of using high-productivity membrane chromatography to achieve intensified and flexible virus manufacturing.
This article discusses the potential of using high-productivity membrane chromatography to achieve intensified and flexible virus manufacturing.
This article discusses the potential of using high-productivity membrane chromatography to achieve intensified and flexible virus manufacturing.